ANDA Dossier Preparation & U.S. FDA Submission Support

An Asia-based mid-sized pharmaceutical company sought to launch a generic anti-hypertensive drug in the U.S. market. 

With limited internal expertise in FDA submissions and facing a tight launch timeline, the client needed end-to-end support for ANDA preparation, compilation, and submission.

Vigilare’s Regulatory Affairs team provided end-to-end support including regulatory strategy, technical file preparation, labeling/packaging compliance, and direct liaison with health authorities.